Avid CEO confident in Alzheimer’s imaging agent

Saturday, July 16th, 2011

PARIS (Reuters) – The chief executive of Eli Lilly and Co’s Alzheimer’s imaging unit is confident it can create a training program for its imaging drug that will satisfy concerns raised by U.S. regulators.

Continue reading here:
Avid CEO confident in ... continue reading